SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
SOLIGENIX, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.34−0.01 (-2.66%)
Close on Oct 19, 2026
- Market cap
- $5.48M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jun 6, 2024 | 1-for-16 reverse | Earlier per-share figures multiplied by 16 |
| Jun 5, 2024 | 1-for-16 reverse | Earlier per-share figures multiplied by 16 |
| Feb 10, 2023 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Feb 10, 2023 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Nov 10, 2016(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Oct 7, 2016 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Feb 1, 2012 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Jun 11, 1997 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |